HomeInsightsEPS

Kabra Drugs Ltd EPS

Kabra Drugs Ltd EPS

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

1.2 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Kabra Drugs Ltd

NSE: KABRADRUGS

EPS

-1.15

Last updated: 16 Sep 24

Key Highlights

  • The Earning per Share of Kabra Drugs Ltd is ₹ -1.15 as of 16 Sep 24.
  • The Earning per Share of Kabra Drugs Ltd changed from ₹ -0.17 to ₹ -1.24 over 9 quarters. This represents a CAGR of 141.85% .

Historical Earning per Share of Kabra Drugs Ltd

No data available

* All values are in

Company Fundamentals for Kabra Drugs Ltd

Market Cap

9 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

2.2

Day’s High *

9.14

Day’s Low

9.14

DTE *

1.6

ROE *

-68.0

52 Week High

9.14

52 Week Low

3.2

ROCE *

-26.4

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Kabra Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
16 Sep 20249.14
02 Sep 20248.71
26 Aug 20248.71
19 Aug 20248.71
12 Aug 20248.71
05 Aug 20248.3
22 Jul 20248.3
08 Jul 20248.3
01 Jul 20247.91
24 Jun 20247.91

BlinkX Score for Kabra Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Kabra Drugs Ltd

Market Value

9

Asset Value

5

1.0 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Historical Market Cap of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Kabra Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Kabra Drugs Ltd

No data available

* All values are in crore

Dividend per Share (DPS) Over Time

No data available

Kabra Drugs Ltd News Hub

News

Kabra Drugs to hold AGM

Kabra Drugs announced that the 35th Annual General Meeting (AGM) of the company will be he...

Read more

16 Sep 202409:56

News

Kabra Drugs to conduct board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 2 September 20...

Read more

28 Aug 202414:54

News

Kabra Drugs announces board meeting date

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2024...

Read more

09 Aug 202415:01

News

Kabra Drugs to conduct board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 12 July 2024. ...

Read more

09 Jul 202409:46

News

Kabra Drugs announces board meeting date

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2024. P...

Read more

25 May 202419:05

News

Kabra Drugs announces board meeting date

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 February 20...

Read more

06 Feb 202412:09

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for EPS of Kabra Drugs Ltd

What is the EPS of Kabra Drugs Ltd stock?

The Earnings Per Share (EPS) of Kabra Drugs Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Kabra Drugs Ltd EPS calculated?

The EPS of Kabra Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Kabra Drugs Ltd report its EPS?

Kabra Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Kabra Drugs Ltd EPS?

Factors that influence the EPS of Kabra Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Kabra Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Kabra Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*